<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for TSPT</title>
    <link />
    <description>Headlines for Transcept Pharmaceuticals</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>SmithOnStocks Opines On Stocks: May 19th Edition</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1445891-smithonstocks-opines-on-stocks-may-19th-edition.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 19 May 2013 20:32:15 GMT</pubDate>
    </item>
    <item>
      <title>Cheerleaders: Look Beyond Pharma For Jobs</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/cheerleaders_look_beyond_pharma_for_jobs.aspx?source=itxwebtxt0000015</link>
      <author>YCharts</author>
      <pubDate>Thu, 16 May 2013 21:05:16 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Downgrades</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/downgrades/13/05/3578410/benzingas-top-downgrades.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 10 May 2013 07:03:32 GMT</pubDate>
    </item>
    <item>
      <title>Transcept Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1416321-transcept-pharmaceuticals-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 18:10:09 GMT</pubDate>
    </item>
    <item>
      <title>Narrower-than-Expected Loss at Seattle Genetics  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98899/narrower-than-expected-loss-at-seattle-genetics.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 09:43:01 GMT</pubDate>
    </item>
    <item>
      <title>Impax Beats Earnings Estimate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98438/impax-beats-earnings-estimate.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 02 May 2013 08:32:01 GMT</pubDate>
    </item>
    <item>
      <title>AMAG Narrows Loss; Maintains View - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97832/amag-narrows-loss-maintains-view.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 24 Apr 2013 16:15:01 GMT</pubDate>
    </item>
    <item>
      <title>Merck - BMY in HCV Deal  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97734/merck-bmy-in-hcv-deal.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 23 Apr 2013 18:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Merck In-Licenses from Xenon  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97618/merck-in-licenses-from-xenon.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 22 Apr 2013 17:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi's Vaccine Gets EU Approval - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97577/sanofis-vaccine-gets-eu-approval.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 22 Apr 2013 12:10:01 GMT</pubDate>
    </item>
    <item>
      <title>PSTI Plans to Start Phase I Study - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97496/psti-plans-to-start-phase-i-study.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 19 Apr 2013 16:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Achillion's HCV Candidates Progress - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97296/achillions-hcv-candidates-progress.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 17 Apr 2013 16:46:01 GMT</pubDate>
    </item>
    <item>
      <title>Actelion Beats Earnings, Sales Rise - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97166/actelion-beats-earnings-sales-rise.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 16 Apr 2013 18:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Repros Gets Additional Patents - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96992/repros-gets-additional-patents.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 12 Apr 2013 16:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi Unveils Bond Issue Pricing - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96648/sanofi-unveils-bond-issue-pricing.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 09 Apr 2013 16:05:01 GMT</pubDate>
    </item>
    <item>
      <title>Positive Data on Repros' Androxal - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96334/positive-data-on-repros-androxal.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 04 Apr 2013 16:43:01 GMT</pubDate>
    </item>
    <item>
      <title>Positive Results on AMAG's Feraheme - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95040/positive-results-on-amags-feraheme.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 18 Mar 2013 17:47:01 GMT</pubDate>
    </item>
    <item>
      <title>Alexion Pharma Upgraded to Outperform - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94892/alexion-pharma-upgraded-to-outperform.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 15 Mar 2013 14:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Transcept Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1231391-transcept-pharmaceuticals-management-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Feb 2013 18:50:17 GMT</pubDate>
    </item>
    <item>
      <title>Transcept: The Prescription Trend Watch For Intermezzo Is On</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1186271-transcept-the-prescription-trend-watch-for-intermezzo-is-on.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 14 Feb 2013 18:29:17 GMT</pubDate>
    </item>
  </channel>
</rss>
